Vanda Pharmaceuticals Inc.
Records under this name other than the patents Vanda Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 130 patents it holds.
Back to Vanda Pharmaceuticals Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,097,738 | Ruthenium (II) catalysts for use in stereoselective cyclopropanations Term ended Ended no later than May 18, 2026 · From the USPTO record | Term ended | Ended no later than May 18, 2026 | From the USPTO record |
| US 8,273,779 | Thiazolidin 4-one derivatives Term ended Term ended Dec 17, 2025 · From the USPTO record | Term ended | Term ended Dec 17, 2025 | From the USPTO record |
| US 9,138,432 | Methods for the administration of iloperidone Term ended Term ended Sep 30, 2025 · From the USPTO record | Term ended | Term ended Sep 30, 2025 | From the USPTO record |
| US 10,272,076 | Methods for the administration of iloperidone Term ended Ended no later than Sep 30, 2025 · From the USPTO record | Term ended | Ended no later than Sep 30, 2025 | From the USPTO record |
| US 8,524,752 | Thiazolidin-4-one derivatives Term ended Term ended Nov 16, 2024 · From the USPTO record | Term ended | Term ended Nov 16, 2024 | From the USPTO record |
| US 9,000,018 | Novel THIAZOLIDIN-4-ONE-DERIVATIVES Term ended Ended no later than Nov 16, 2024 · Low confidence | Term ended | Ended no later than Nov 16, 2024 | Low confidence |
| US RE43,833 | THIAZOLIDIN-4-ONE Derivatives Term ended Term ended Nov 16, 2024 · Low confidence | Term ended | Term ended Nov 16, 2024 | Low confidence |
| US RE45,174 | THIAZOLIDIN-4-ONE Derivatives Term ended Term ended Nov 16, 2024 · Low confidence | Term ended | Term ended Nov 16, 2024 | Low confidence |
| US 7,977,356 | Optical isomers of an Iloperidone metabolite Term ended Term ended Sep 16, 2024 · From the USPTO record | Term ended | Term ended Sep 16, 2024 | From the USPTO record |
| US 8,314,129 | Optical Isomers of an Iloperidone Metabolite Term ended Term ended Sep 16, 2024 · Medium confidence | Term ended | Term ended Sep 16, 2024 | Medium confidence |